Indaptus Therapeutics, Inc. (INDP) Tops Q2 EPS by 2c

Indaptus Therapeutics, Inc. (NASDAQ: INDP) reported Q2 EPS of ($0.46), $0.02 better than the analyst estimate of ($0.48).

For earnings history and earnings-related data on Indaptus Therapeutics, Inc. (INDP) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c